Antiphopholipid antibodies and functional activated protein C resistance in patients with breast cancer during anthracycline-based chemotherapy administered through an intravenous port-catheter device

A tétel rövid nézete
dc.contributor.authorSoliman, Amr A.
dc.contributor.authorCsorba, Roland
dc.contributor.authorUllrich, A.
dc.contributor.authorTsikouras, Panagioti
dc.contributor.authorRath, Werner
dc.contributor.authorTempelhoff, Georg-Friedrich von
dc.date.accessioned2018-01-31T14:49:51Z
dc.date.available2018-01-31T14:49:51Z
dc.date.issued2014
dc.date.oa2018-09-05
dc.date.pasync2018-02-10T01:30:18Z
dc.date.updated2018-02-10T01:30:18Z
dc.description.correctorLB
dc.identifier.citationClinical And Applied Thrombosis-Hemostasis. - 20 : 3 (2014), p. 338-340. -Clin. Appl. Thromb.-Hemost. - 1076-0296
dc.identifier.doihttp://dx.doi.org/10.1177/1076029613508598
dc.identifier.issn1076-0296
dc.identifier.opachttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM072237
dc.identifier.urihttp://hdl.handle.net/2437/247844
dc.identifier.urlhttp://journals.sagepub.com/doi/10.1177/1076029613508598
dc.languageeng
dc.rights.accessopen access journal
dc.rights.ownerSAGE Publications
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleAntiphopholipid antibodies and functional activated protein C resistance in patients with breast cancer during anthracycline-based chemotherapy administered through an intravenous port-catheter device
dc.typefolyóiratcikk
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nem elérhető
Név:
FILE_UP_0_Csorba_Antiphopholipid_antibodies_and_functional_activated_protein_2014_20_3.pdf
Méret:
134.61 KB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat
Letöltés
Gyűjtemények
Publikációs Adatbázis